Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
In the latest session, Aptevo Therapeutics Inc (NASDAQ: APVO) closed at $1.42 down -2.74% from its previous closing price of $1.46. In other words, the price has decreased by -$2.74 from its previous closing price. On the day, 0.72 million shares were traded. APVO stock price reached its highest trading level at $1.4705 during the session, while it also had its lowest trading level at $1.41.
Ratios:
For a deeper understanding of Aptevo Therapeutics Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.27 and its Current Ratio is at 2.27. In the meantime, Its Debt-to-Equity ratio is 0.65 whereas as Long-Term Debt/Eq ratio is at 0.65.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, APVO now has a Market Capitalization of 19608732 and an Enterprise Value of -532156.
Stock Price History:
The Beta on a monthly basis for APVO is 5.92, which has changed by -0.9928929 over the last 52 weeks, in comparison to a change of 0.20772064 over the same period for the S&P500. Over the past 52 weeks, APVO has reached a high of $298.00, while it has fallen to a 52-week low of $1.32. The 50-Day Moving Average of the stock is -11.89%, while the 200-Day Moving Average is calculated to be -93.47%.
Shares Statistics:
For the past three months, APVO has traded an average of 5.52M shares per day and 857480 over the past ten days. A total of 13.81M shares are outstanding, with a floating share count of 13.81M. Insiders hold about 0.00% of the company’s shares, while institutions hold 11.06% stake in the company. Shares short for APVO as of 1760486400 were 899341 with a Short Ratio of 0.16, compared to 1757894400 on 43940. Therefore, it implies a Short% of Shares Outstanding of 899341 and a Short% of Float of 6.510000000000001.
Earnings Estimates
A detailed examination of Aptevo Therapeutics Inc (APVO) is currently in progress, with 1.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is -$1.9, with high estimates of -$1.9 and low estimates of -$1.9.
Analysts are recommending an EPS of between -$14.18 and -$14.18 for the fiscal current year, implying an average EPS of -$14.18. EPS for the following year is -$7.42, with 1.0 analysts recommending between -$7.42 and -$7.42.
